Nasdaq Stocks

In the latest trading session, Fortinet (FTNT) closed at $117.31, marking a +0.43% move from the previous day. This change lagged the S&P 500's 1.61% gain on the day. At the same time, the Dow added 1.51%, and the tech-heavy Nasdaq gained 1.87%.

In the latest trading session, Fastly (FSLY) closed at $90.80, marking a -0.72% move from the previous day. This change lagged the S&P 500's 1.61% gain on the day. At the same time, the Dow added 1.51%, and the tech-heavy Nasdaq gained 1.87%.

JD.com, Inc. (JD) closed at $76.10 in the latest trading session, marking a +1.92% move from the prior day. The stock outpaced the S&P 500's daily gain of 1.61%. Elsewhere, the Dow gained 1.51%, while the tech-heavy Nasdaq added 1.87%.

The global cannabis market is booming: it’s set to reach $146 billion by 2025. There is a rapidly growing demand for cannabinoids, the compounds found in the cannabis plant.

Alexion Pharmaceuticals, Inc. ALXN announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Ultomiris (ravulizumab) for adults and children living with atypical hemolytic uremic syndrome (aHUS). Ultomiris is the first and only long-acting C5 inhibitor fo

Gilead Sciences, Inc. GILD and partner Galapagos NV GLPG announced that the European Commission (EC) has granted marketing authorization to rheumatoid arthritis (RA) drug, Jyseleca (filgotinib 200 mg and 100 mg tablets).

Oracle ORCL recently added new tools — Cloud Guard and Maximum Security Zones —  to its Oracle Cloud Infrastructure (OCI) to boost security for customers. The tools will be available across all its cloud commercial regions at no extra cost.

Hawaiian Holdings’ HA subsidiary Hawaiian Airlines will begin offering drive-through COVID-19 tests to travelers from select U.S. mainland cities so that they can escape Hawaii's mandatory 14-day quarantine requirement in case they test negative. Following this news, shares of

Big Lots, Inc. BIG continues to cheer investors based on the stock’s bullish run on bourses, thanks to robust business strategies. The company’s transformation initiative, referred to as Operation North Star, focuses on driving top-line growth, cost containment, and enhancem

Delta Air Lines Inc DAL plans to retire some of its aircraft earlier than scheduled as part of its fleet-simplification strategy, aimed at modernizing the carrier’s fleet, enhancing customer experience as well as generating cost savings. To this end, the airline has decided to

The board of directors of Artesian Resources Corporation (ARTNA recently approved a 3% hike in the company’s Class A and Class B common stock dividend, thereby bringing the annual dividend to $1.0284 per share. This quarterly dividend of 25.71 cents per share will be payable N

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

Blueprint Medicines Corporation BPMC announced that the European Commission (EC) has granted conditional marketing authorization to its lead drug Ayvakyt (avapritinib) as a monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal t

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its cystic fibrosis (CF) drug Kalydeco (ivacaftor) for an expanded use in infants aged between four and less than six months with at least one mutation in their CFTR gene that is responsive to Kalydeco.

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?

Molson Coors Brewing (TAP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.